E-viri
Recenzirano
Odprti dostop
-
Marciano, Beatriz E., MD; Huang, Chiung-Yu, PhD; Joshi, Gyan, PhD; Rezaei, Nima, MD; Carvalho, Beatriz Costa, MD; Allwood, Zoe, MD; Ikinciogullari, Aydan, MD; Reda, Shereen M., MD; Gennery, Andrew, MD; Thon, Vojtech, MD; Espinosa-Rosales, Francisco, MD; Al-Herz, Waleed, MD; Porras, Oscar, MD; Shcherbina, Anna, MD; Szaflarska, Anna, MD; Kiliç, Şebnem, MD; Franco, Jose L., MD, PhD; Gómez Raccio, Andrea C., MD; Roxo, Persio, MD; Esteves, Isabel, MD; Galal, Nermeen, MD; Grumach, Anete Sevciovic, MD, PhD; Al-Tamemi, Salem, MD; Yildiran, Alisan, MD; Orellana, Julio C., MD; Yamada, Masafumi, MD; Morio, Tomohiro, MD; Liberatore, Diana, MD; Ohtsuka, Yoshitoshi, MD; Lau, Yu-Lung, MD; Nishikomori, Ryuta, MD; Torres-Lozano, Carlos, MD; Mazzucchelli, Juliana T.L., MD; Vilela, Maria M.S., MD; Tavares, Fabiola S., MD; Cunha, Luciana, MD; Pinto, Jorge A., MD; Espinosa-Padilla, Sara E., MD; Hernandez-Nieto, Leticia, MD; Elfeky, Reem A., MD; Ariga, Tadashi, MD; Toshio, Heike, MD; Dogu, Figen, MD; Cipe, Funda, MD; Formankova, Renata, MD; Nuñez-Nuñez, M. Enriqueta, MD; Bezrodnik, Liliana, MD; Marques, Jose Gonçalo, MD; Pereira, María I., PhD; Listello, Viviana, MD; Slatter, Mary A., MD; Nademi, Zohreh, MD; Kowalczyk, Danuta, MD; Fleisher, Thomas A., MD; Davies, Graham, MD; Neven, Bénédicte, MD; Rosenzweig, Sergio D., MD, PhD
Journal of allergy and clinical immunology, 04/2014, Letnik: 133, Številka: 4Journal Article
Background Severe combined immunodeficiency (SCID) is a syndrome characterized by profound T-cell deficiency. BCG vaccine is contraindicated in patients with SCID. Because most countries encourage BCG vaccination at birth, a high percentage of patients with SCID are vaccinated before their immune defect is detected. Objectives We sought to describe the complications and risks associated with BCG vaccination in patients with SCID. Methods An extensive standardized questionnaire evaluating complications, therapeutics, and outcomes regarding BCG vaccination in patients given a diagnosis of SCID was widely distributed. Summary statistics and association analysis was performed. Results Data on 349 BCG-vaccinated patients with SCID from 28 centers in 17 countries were analyzed. Fifty-one percent of the patients had BCG-associated complications, 34% disseminated and 17% localized (a 33,000- and 400-fold increase, respectively, over the general population). Patients receiving early vaccination (≤1 month) showed an increased prevalence of complications ( P = .006) and death caused by BCG-associated complications ( P < .0001). The odds of experiencing complications among patients with T-cell numbers of 250/μL or less at diagnosis was 2.1 times higher (95% CI, 1.4-3.4 times higher; P = .001) than among those with T-cell numbers of greater than 250/μL. BCG-associated complications were reported in 2 of 78 patients who received antimycobacterial therapy while asymptomatic, and no deaths caused by BCG-associated complications occurred in this group. In contrast, 46 BCG-associated deaths were reported among 160 patients treated with antimycobacterial therapy for a symptomatic BCG infection ( P < .0001). Conclusions BCG vaccine has a very high rate of complications in patients with SCID, which increase morbidity and mortality rates. Until safer and more efficient antituberculosis vaccines become available, delay in BCG vaccination should be considered to protect highly vulnerable populations from preventable complications.
Avtor
Vnos na polico
Trajna povezava
- URL:
Faktor vpliva
Dostop do baze podatkov JCR je dovoljen samo uporabnikom iz Slovenije. Vaš trenutni IP-naslov ni na seznamu dovoljenih za dostop, zato je potrebna avtentikacija z ustreznim računom AAI.
Leto | Faktor vpliva | Izdaja | Kategorija | Razvrstitev | ||||
---|---|---|---|---|---|---|---|---|
JCR | SNIP | JCR | SNIP | JCR | SNIP | JCR | SNIP |
Baze podatkov, v katerih je revija indeksirana
Ime baze podatkov | Področje | Leto |
---|
Povezave do osebnih bibliografij avtorjev | Povezave do podatkov o raziskovalcih v sistemu SICRIS |
---|
Vir: Osebne bibliografije
in: SICRIS
To gradivo vam je dostopno v celotnem besedilu. Če kljub temu želite naročiti gradivo, kliknite gumb Nadaljuj.